ATE323490T1 - Farnesyl-protein-transferasehemmer zur behandlung der entzündlichen darmerkrankung - Google Patents
Farnesyl-protein-transferasehemmer zur behandlung der entzündlichen darmerkrankungInfo
- Publication number
- ATE323490T1 ATE323490T1 AT01998349T AT01998349T ATE323490T1 AT E323490 T1 ATE323490 T1 AT E323490T1 AT 01998349 T AT01998349 T AT 01998349T AT 01998349 T AT01998349 T AT 01998349T AT E323490 T1 ATE323490 T1 AT E323490T1
- Authority
- AT
- Austria
- Prior art keywords
- treatment
- inflammatory bowel
- bowel disease
- inhibitors
- transfera
- Prior art date
Links
- 208000022559 Inflammatory bowel disease Diseases 0.000 title abstract 2
- JXBSHSBNOVLGHF-BUJBXKITSA-N (6E,10E)-2,6,10-trimethyldodeca-2,6,10-triene Chemical compound C\C=C(/C)CC\C=C(/C)CCC=C(C)C JXBSHSBNOVLGHF-BUJBXKITSA-N 0.000 title 1
- 239000003112 inhibitor Substances 0.000 title 1
- 102000004169 proteins and genes Human genes 0.000 title 1
- 108090000623 proteins and genes Proteins 0.000 title 1
- 239000003814 drug Substances 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 239000003528 protein farnesyltransferase inhibitor Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4704—2-Quinolinones, e.g. carbostyril
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Enzymes And Modification Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US25334600P | 2000-11-28 | 2000-11-28 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE323490T1 true ATE323490T1 (de) | 2006-05-15 |
Family
ID=22959893
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT01998349T ATE323490T1 (de) | 2000-11-28 | 2001-11-20 | Farnesyl-protein-transferasehemmer zur behandlung der entzündlichen darmerkrankung |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20040044032A1 (de) |
| EP (1) | EP1339407B1 (de) |
| JP (1) | JP4231691B2 (de) |
| AT (1) | ATE323490T1 (de) |
| AU (1) | AU2002218311A1 (de) |
| CY (1) | CY1106122T1 (de) |
| DE (1) | DE60118953T2 (de) |
| DK (1) | DK1339407T3 (de) |
| ES (1) | ES2261523T3 (de) |
| PT (1) | PT1339407E (de) |
| WO (1) | WO2002043733A1 (de) |
Families Citing this family (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2547518A1 (en) | 2003-12-12 | 2005-06-30 | Wyeth | Quinolines useful in treating cardiovascular disease |
| CA2559221A1 (en) * | 2004-03-18 | 2005-09-29 | Brigham And Women's Hospital, Inc. | Methods for the treatment of synucleinopathies |
| WO2005089515A2 (en) * | 2004-03-18 | 2005-09-29 | The Brigham And Women's Hospital, Inc. | Methods for the treatment of synucleinopathies |
| WO2005089496A2 (en) * | 2004-03-18 | 2005-09-29 | The Brigham And Women's Hospital, Inc. | Methods for the treatment of synucleinopathies |
| US20070293539A1 (en) * | 2004-03-18 | 2007-12-20 | Lansbury Peter T | Methods for the treatment of synucleinopathies |
| CA2559285A1 (en) * | 2004-03-18 | 2005-09-29 | Brigham And Women's Hospital, Inc. | Methods for the treatment of synucleinopathies |
| PL2362218T3 (pl) | 2004-11-05 | 2015-02-27 | Janssen Pharmaceutica Nv | Sposoby kontroli skuteczności inhibitorów transferazy farnezylowej |
| EP2545919A1 (de) | 2005-12-23 | 2013-01-16 | Link Medicine Corporation | Behandlung von Synucleinopathien |
| WO2009151683A2 (en) * | 2008-03-12 | 2009-12-17 | Link Medicine Corporation | Quinolinone farnesyl transferase inhibitors for the treatment of synucleinopathies and other indications |
| WO2010057006A1 (en) * | 2008-11-13 | 2010-05-20 | Link Medicine Corporation | Azaquinolinone derivatives and uses thereof |
| US20100331363A1 (en) * | 2008-11-13 | 2010-12-30 | Link Medicine Corporation | Treatment of mitochondrial disorders using a farnesyl transferase inhibitor |
| US20110060005A1 (en) * | 2008-11-13 | 2011-03-10 | Link Medicine Corporation | Treatment of mitochondrial disorders using a farnesyl transferase inhibitor |
| PT2909192T (pt) | 2012-10-16 | 2017-08-04 | Janssen Pharmaceutica Nv | Moduladores de ror-gama-t quinolinilo ligados por metileno |
| ES2619610T3 (es) | 2012-10-16 | 2017-06-26 | Janssen Pharmaceutica Nv | Moduladores de ROR-gamma-t de quinolinilo enlazado con heteroarilo |
| SG11201502935VA (en) | 2012-10-16 | 2015-09-29 | Janssen Pharmaceutica Nv | Phenyl linked quinolinyl modulators of ror-gamma-t |
| US10555941B2 (en) | 2013-10-15 | 2020-02-11 | Janssen Pharmaceutica Nv | Alkyl linked quinolinyl modulators of RORγt |
| US9328095B2 (en) | 2013-10-15 | 2016-05-03 | Janssen Pharmaceutica Nv | Heteroaryl linked quinolinyl modulators of RORgammat |
| US9403816B2 (en) | 2013-10-15 | 2016-08-02 | Janssen Pharmaceutica Nv | Phenyl linked quinolinyl modulators of RORγt |
| JP6423423B2 (ja) | 2013-10-15 | 2018-11-14 | ヤンセン ファーマシューティカ エヌ．ベー． | Ｒｏｒγｔのアルキル結合キノリニルモジュレーター |
| US9284308B2 (en) | 2013-10-15 | 2016-03-15 | Janssen Pharmaceutica Nv | Methylene linked quinolinyl modulators of RORγt |
| EP3057422B1 (de) | 2013-10-15 | 2019-05-15 | Janssen Pharmaceutica NV | Chinolinylmodulatoren von ror(gamma)t |
| US9221804B2 (en) | 2013-10-15 | 2015-12-29 | Janssen Pharmaceutica Nv | Secondary alcohol quinolinyl modulators of RORγt |
| PL3640345T3 (pl) | 2015-08-17 | 2022-02-07 | Kura Oncology, Inc. | Sposoby leczenia pacjentów z nowotworem z użyciem inhibitorów farnezylotransferazy |
| ES2863730T3 (es) | 2016-11-03 | 2021-10-11 | Kura Oncology Inc | Inhibidores de la farnesiltransferasa para uso en el tratamiento del cáncer |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2146126A1 (en) * | 1992-10-07 | 1994-04-14 | Sumitomo Pharmaceuticals Company, Limited | Pharmaceutical compositions for inhibiting the formation of tumor necrosis factor |
| US5470832A (en) * | 1994-01-31 | 1995-11-28 | Merck & Co., Inc. | Inhibitors of geranylgeranyl-protein transferase |
| US5574025A (en) * | 1994-10-26 | 1996-11-12 | Merck & Co., Inc. | Inhibitors of prenyl-protein transferases |
| TW316902B (de) * | 1994-12-28 | 1997-10-01 | Janssen Pharmaceutica Nv | |
| TW349948B (en) * | 1995-10-31 | 1999-01-11 | Janssen Pharmaceutica Nv | Farnesyl transferase inhibiting 2-quinolone derivatives |
| EP1162201B1 (de) * | 1995-12-08 | 2006-03-29 | Janssen Pharmaceutica N.V. | (Imidazol-5-yl)Methyl-2-Chinolinonderivate als Farnesyl Protein transferase Inhibitoren |
| US6011029A (en) * | 1996-02-26 | 2000-01-04 | Bristol-Myers Squibb Company | Inhibitors of farnesyl protein transferase |
| US5929077A (en) * | 1996-11-08 | 1999-07-27 | Leftheris; Katerina | Thioproline-containing inhibitors of farnesyl protein transferase |
| TW591030B (en) * | 1997-03-10 | 2004-06-11 | Janssen Pharmaceutica Nv | Farnesyl transferase inhibiting 1,8-annelated quinolinone derivatives substituted with N- or C-linked imidazoles |
| GB2323783A (en) * | 1997-04-02 | 1998-10-07 | Ferring Bv Group Holdings | Inhibitors of farnesyl protein transferase |
| US6177432B1 (en) * | 1997-04-25 | 2001-01-23 | Janssen-Cilag S.A. | Farnesyltransferase inhibiting quinazolinones |
| TW527355B (en) * | 1997-07-02 | 2003-04-11 | Bristol Myers Squibb Co | Inhibitors of farnesyl protein transferase |
| WO1999026657A1 (en) * | 1997-11-25 | 1999-06-03 | Musc Foundation For Research Development | Inhibitors of nitric oxide synthase |
| US6458800B1 (en) * | 1998-12-23 | 2002-10-01 | Janssen Pharmaceutica N.V. | 1,2-annelated quinoline derivatives |
-
2001
- 2001-11-20 EP EP01998349A patent/EP1339407B1/de not_active Expired - Lifetime
- 2001-11-20 US US10/433,243 patent/US20040044032A1/en not_active Abandoned
- 2001-11-20 ES ES01998349T patent/ES2261523T3/es not_active Expired - Lifetime
- 2001-11-20 PT PT01998349T patent/PT1339407E/pt unknown
- 2001-11-20 WO PCT/EP2001/013540 patent/WO2002043733A1/en not_active Ceased
- 2001-11-20 JP JP2002545703A patent/JP4231691B2/ja not_active Expired - Lifetime
- 2001-11-20 DE DE60118953T patent/DE60118953T2/de not_active Expired - Lifetime
- 2001-11-20 AU AU2002218311A patent/AU2002218311A1/en not_active Abandoned
- 2001-11-20 AT AT01998349T patent/ATE323490T1/de active
- 2001-11-20 DK DK01998349T patent/DK1339407T3/da active
-
2006
- 2006-07-18 CY CY20061100996T patent/CY1106122T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| ES2261523T3 (es) | 2006-11-16 |
| PT1339407E (pt) | 2006-08-31 |
| DE60118953D1 (de) | 2006-05-24 |
| US20040044032A1 (en) | 2004-03-04 |
| JP4231691B2 (ja) | 2009-03-04 |
| WO2002043733A1 (en) | 2002-06-06 |
| DE60118953T2 (de) | 2007-01-11 |
| DK1339407T3 (da) | 2006-08-14 |
| AU2002218311A1 (en) | 2002-06-11 |
| EP1339407A1 (de) | 2003-09-03 |
| CY1106122T1 (el) | 2011-06-08 |
| JP2004514695A (ja) | 2004-05-20 |
| EP1339407B1 (de) | 2006-04-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE323490T1 (de) | Farnesyl-protein-transferasehemmer zur behandlung der entzündlichen darmerkrankung | |
| CY1105477T1 (el) | Αναστολεις τρανσφepασης φαρνεσυλ πρωτεϊνης για τη θepαπευτικη αντιμετωπιση του καρκινου του μαστου | |
| DE60124302D1 (de) | Thiazolderivate zur behandlung von ppar-lierte krankheiten | |
| DE60123238D1 (de) | Zusammensetzungen zur behandlung von autoimmunkrankheiten | |
| ATE390407T1 (de) | Phenethanolamin-derivate zur behandlung von atemwegserkrankungen | |
| DE60230425D1 (de) | Phenethanolamin-derivate zur behandlung von erkrankungen der atemwege | |
| HRP20040758B1 (hr) | Uporaba il-18 inhibitora za lijeäśenje i/ili prevenciju perifernih krvožilnih bolesti | |
| DE60335560D1 (de) | Zusammensetzungen enthaltend zitronensäure zur behandlung von nagelpilzerkrankungen | |
| ATE384522T1 (de) | Medikamente zur chemotherapeutischen behandlung von erkrankungen | |
| DK1456380T3 (da) | SMAD7-inhibitorer til behandling af CNS-sygdomme | |
| ATE451123T1 (de) | Vaginal verabreichbare zusammensetzung zur behandlung von uteriner dysrhythmie | |
| ATE338036T1 (de) | Zur behandlung hyperproliferativer erkrankungen geeignete benzofuran- und benzothiophenderivate | |
| DE50013843D1 (de) | Arzneimittel zur behandlung von darmerkrankungen | |
| ATE522218T1 (de) | Dosierungseinheit enthaltend prostaglandin-analog zur behandlung von darmverstopfung | |
| DE60236743D1 (de) | Zur behandlung androgenabhängiger krankheiten | |
| TNSN06138A1 (fr) | Inhibitors of the mutant form of kit | |
| ATE271861T1 (de) | Verwendung von nmda-antagonisten und/oder natriumkanalantagonisten zur behandlung von entzündlichen erkrankungen | |
| ATE290384T1 (de) | Etherlysophospholipide zur behandlung von chronischen entzündlichen erkrankungen | |
| EP1594435A4 (de) | Hemmung der hiv-1-replikation durch störung der verarbeitung des viralen capsid-spacer peptid 1 proteins | |
| DE60042161D1 (de) | Ppar delta-inhibitoren zur behandlung kardiovasculärer erkrankungen | |
| DE60120990D1 (de) | Verwendung von 3-bezoylphenylessigsäure-derivaten zur behandlung von netzhauterkrankungen | |
| DE60131968D1 (de) | PYRANOÄ2,3-cÜIMIDAZOÄ1,2-aÜPYRIDIN-DERIVATE ZUR BEHANDLUNG VON GASTROINTESTINALEN ERKRANKUNGEN | |
| ATE374197T1 (de) | Indolderivate zur behandlung von erkrankungen des zentralnervensystems | |
| ATE536874T1 (de) | Dreifache monoamin-wiederaufnahmehemmer zur behandlung von chronischen schmerzen | |
| ATE330938T1 (de) | Disulfid-derivate verwendbar zur behandlung von allergischen erkrankungen |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |
Ref document number: 1339407 Country of ref document: EP |